{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:44:01Z","timestamp":1767840241522,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T00:00:00Z","timestamp":1279929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00296-010-1571-6","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T05:22:08Z","timestamp":1279862528000},"page":"33-37","source":"Crossref","is-referenced-by-count":16,"title":["High incidence of intolerance to tuberculosis chemoprophylaxis"],"prefix":"10.1007","volume":"32","author":[{"given":"Muhammad","family":"Haroon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Una","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,24]]},"reference":[{"key":"1571_CR1","unstructured":"http:\/\/www.isr.ie\/_fileupload\/File\/ISR%20Guidelines%20A4%20(3).pdf"},{"key":"1571_CR2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","volume":"60","author":"British Thoracic Society, Standards of Care Committee","year":"2005","unstructured":"British Thoracic Society, Standards of Care Committee (2005) BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-{alpha} treatment. Thorax 60:800\u2013805","journal-title":"Thorax"},{"key":"1571_CR3","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199510263331706","volume":"333","author":"WM Lee","year":"1995","unstructured":"Lee WM (1995) Drug-induced hepatotoxicity. N Engl J Med 333:1118\u20131127","journal-title":"N Engl J Med"},{"key":"1571_CR4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/0003-4819-84-2-181","volume":"84","author":"JR Mitchell","year":"1976","unstructured":"Mitchell JR, Zimmerman HJ, Ishak KG et al (1976) Isoniazid liver injury: clinical spectrum, pathology and probable pathogenesis. Ann Intern Med 84:181\u2013192","journal-title":"Ann Intern Med"},{"issue":"4","key":"1571_CR5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ard.2007.076406","volume":"67","author":"A Mor","year":"2008","unstructured":"Mor A, Bingham CO 3rd, Kishimoto M, Izmirly PM, Greenberg JD, Reddy S, Rosenthal PB (2008) Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic. Ann Rheum Dis 67(4):462\u2013465","journal-title":"Ann Rheum Dis"},{"key":"1571_CR6","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/archinte.159.21.2542","volume":"159","author":"V Strand","year":"1999","unstructured":"Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G et al (1999) Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med 159:2542\u20132550","journal-title":"Arch Intern Med"},{"issue":"11","key":"1571_CR7","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3899\/jrheum.080521","volume":"35","author":"AM Leak","year":"2008","unstructured":"Leak AM, Rincon-Aznar B (2008) Hepatotoxicity associated with etanercept in psoriatic arthritis. J Rheumatol 35(11):2286\u20132287","journal-title":"J Rheumatol"},{"issue":"5","key":"1571_CR8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10067-006-0253-y","volume":"26","author":"AM Garcia Aparicio","year":"2007","unstructured":"Garcia Aparicio AM, Rey JR, Sanz AH, Alvarez JS (2007) Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab. Clin Rheumatol 26(5):811\u2013813","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1571_CR9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.24476","volume":"61","author":"P Brassard","year":"2009","unstructured":"Brassard P, Lowe AM, Bernatsky S, Kezouh A, Suissa S (2009) Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada. Arthritis Rheum 61(3):300\u2013304","journal-title":"Arthritis Rheum"},{"key":"1571_CR10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","volume":"59","author":"KG Saag","year":"2008","unstructured":"Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR et al (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59:762\u2013784","journal-title":"Arthritis Rheum"},{"key":"1571_CR11","first-page":"683","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","unstructured":"Centers for Disease Control and Prevention (2004) Tuberculosis associated with blocking agents against tumor necrosis factor-alpha\u2014California, 2002\u20132003. MMWR Morb Mortal Wkly Rep 53:683\u2013686","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"1571_CR12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/BOR.0b013e3283025ec2","volume":"20","author":"J Keane","year":"2008","unstructured":"Keane J, Bresnihan B (2008) Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies. Curr Opin Rheumatol 20(4):443\u2013449","journal-title":"Curr Opin Rheumatol"},{"key":"1571_CR13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-147-10-200711200-00006","volume":"147","author":"A Raval","year":"2007","unstructured":"Raval A, Akhavan-Toyserkani G, Brinker A et al (2007) Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab. Ann Intern Med 147:699\u2013702","journal-title":"Ann Intern Med"},{"issue":"5","key":"1571_CR14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","volume":"57","author":"JJ G\u00f3mez-Reino","year":"2007","unstructured":"G\u00f3mez-Reino JJ, Carmona L, Angel Descalzo M, Biobadaser Group (2007) Risk of tuberculosis in patients treated with tumour necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 57(5):756\u2013761","journal-title":"Arthritis Rheum"},{"key":"1571_CR15","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","volume":"52","author":"L Carmona","year":"2005","unstructured":"Carmona L, G\u00f3mez-Reino JJ, Rodr\u00edguez-Valverde V et al (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52:1766\u20131772","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1571_CR16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10067-008-0982-1","volume":"28","author":"I Sezer","year":"2009","unstructured":"Sezer I, Kocabas H, Melikoglu MA, Arman M (2009) Positiveness of purified protein derivatives in rheumatoid arthritis patients who are not receiving immunosuppressive therapy. Clin Rheumatol 28(1):53\u201357","journal-title":"Clin Rheumatol"},{"issue":"10","key":"1571_CR17","first-page":"1127","volume":"10","author":"L Sichletidis","year":"2006","unstructured":"Sichletidis L, Settas L, Spyratos D, Chloros D, Patakas D (2006) Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis. Int J Tuberc Lung Dis 10(10):1127\u20131132","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"1571_CR18","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/ard.2002.004598","volume":"62","author":"J Vanhoof","year":"2003","unstructured":"Vanhoof J, Landewe S, Van Wijngaerden E, Geusens P (2003) High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors. Ann Rheum Dis 62(12):1241\u20131242","journal-title":"Ann Rheum Dis"},{"key":"1571_CR19","unstructured":"Smieja MJ, Marchetti CA, Cook DJ, Smaill FM (2000) Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev (2):CD001363"},{"key":"1571_CR20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/ajrccm\/145.1.36","volume":"145","author":"Hong Kong Chest Service","year":"1992","unstructured":"Hong Kong Chest Service, Tuberculosis Research Centre Madras, British Medical Research Council (1992) A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 145:36\u201341","journal-title":"Am Rev Respir Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1571-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-010-1571-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1571-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:18:44Z","timestamp":1559027924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-010-1571-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,24]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1571"],"URL":"https:\/\/doi.org\/10.1007\/s00296-010-1571-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,24]]}}}